1 week Ago By ABMN Staff
New York Life Investment Management LLC boosted its stake in Medtronic plc ( NYSE:MDT – Free Report ) by 0.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 186,437 shares of the medical technology company’s stock after purchasing an additional 466 shares during the period.
New York Life Investment Management LLC’s holdings in Medtronic were worth $14,674,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. International Assets Investment Management LLC raised its stake in shares of Medtronic by 2.
5% during the fourth quarter. International Assets Investment Management LLC now owns 12,607 shares of the medical technology company’s stock valued at $1,039,000 after acquiring an additional 302 shares during the last quarter. Gryphon Financial Partners LLC bought a new stake in shares of Medtronic in the 4th quarter worth approximately $220,000.
Teacher Retirement System of Texas increased its stake in shares of Medtronic by 0.5% during the fourth quarter. Teacher Retirement System of Texas now owns 296,845 shares of the medical technology company’s stock valued at $24,454,000 after buying an additional 1,364 shares during the period.
Cary Street Partners Investment Advisory LLC raised its holdings in shares of Medtronic by 3.0% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 34,327 shares of the medical technology company’s stock valued at $2,828,000 after acquiring an additional 985 shares in the last quarter.
Finally, AGF Management Ltd. purchased a new stake in Medtronic in the fourth quarter worth $822,000. Institutional investors own 82.
06% of the company’s stock. Medtronic Stock Up 0.6 % NYSE:MDT opened at $89.
89 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.
61 and a current ratio of 2.13. The firm has a market cap of $115.
26 billion, a P/E ratio of 32.69, a P/E/G ratio of 2.52 and a beta of 0.
84. Medtronic plc has a fifty-two week low of $68.84 and a fifty-two week high of $91.
49. The firm has a 50-day simple moving average of $82.29 and a two-hundred day simple moving average of $82.
60. Medtronic Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be given a $0.
70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 3.
11%. The ex-dividend date of this dividend is Friday, September 27th. Medtronic’s dividend payout ratio (DPR) is 101.
82%. Wall Street Analysts Forecast Growth Several research firms have recently commented on MDT. The Goldman Sachs Group started coverage on shares of Medtronic in a research report on Thursday, May 30th.
They issued a “sell” rating and a $83.00 target price for the company. Robert W.
Baird upped their target price on Medtronic from $82.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st.
Royal Bank of Canada restated a “sector perform” rating and issued a $92.00 target price on shares of Medtronic in a research note on Wednesday, August 21st. Barclays upped their price target on Medtronic from $104.
00 to $105.00 and gave the stock an “overweight” rating in a research note on Thursday, August 22nd. Finally, UBS Group upgraded Medtronic from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $76.
00 to $90.00 in a report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company.
According to data from MarketBeat, Medtronic currently has a consensus rating of “Hold” and a consensus price target of $92.92. Read Our Latest Report on Medtronic Medtronic Company Profile ( Free Report ) Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. Further Reading Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc ( NYSE:MDT – Free Report ).
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter ..
